Journal of Immunooncology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 

Editorial Board

Editor Image

Xin Wang
Cleveland Clinic Lerner Research Institute
USA

Editor Image

Kai Kang
Cleveland Clinic Lerner Research Institute
USA

Editor Image

Debasis Pore
Cleveland Clinic
USA

View More»

Recommended Conferences

View More»
 

Submit Manuscript


Submit manuscript at http://www.editorialmanager.com/medicaljournals/ or send as an e-mail attachment to the Editorial Office at immunooncol@immunologyjournals.com
 

About the Journal

Journal of Immunooncology is one of the most promising and rapidly developing areas of cancer research. The journal focuses on the development of new therapies which improve human body’s immune response against cancer.

Journal of Immunooncology is focused on publishing articles on various areas of immunotherapy like cancer immunotherapy, tumor immunology, immune system, nucleic acid research, immune suppression, immunosurveillance, tumor immunity, cellular immunotherapy, cancer radioimmunotherapy, cancer immunology, cancer immunoediting, immunotherapeutics, immunogenicity and recent research in these areas. The Journal provides an open access platform to publish latest advancements in all aspects related to immune-oncology.

This Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on any array of Immuno-oncology. The Journal of Immunooncology is a Peer Reviewed Open Access Journal supported by universally prominent Editorial Board members. Abstracts and full texts of all articles published by Journal of Immunooncology are freely accessible to everyone immediately after publication.

The journal is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking system. Review processing is performed by the editorial board members of Journal of Immunooncology or outside experts; approval of at least two independent reviewers followed by the editor is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

Cancer Immunotherapies

Cancer Immunotherapies is the treatment that uses certain parts of the immune system to fight against diseases like cancer. It is also known as biotherapy or biologic therapy. Antibody therapies are the most successful immunotherapy as it treats wide range of cancers. Immunotherapies fall into three main groups: cellular, antibody and cytokine.

Related Journals of Cancer Immunotherapies

Immunobiology, Immunotherapy: Open Access, Immunome Research, Cancer Immunology and Immunotherapy, Journal of Immunotherapy, International Journal of Immunotherapy

Immunotherapies

Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function. It is not actually clear how immunotherapy treats cancer.

Related Journals of Immunotherapies

Immunobiology, Immunotherapy: Open Access, Immunome Research, Cancer Immunology and Immunotherapy, Journal of Immunotherapy, Immunotherapy, International Journal of Immunotherapy

Tumour Immunology

Tumour Immunology is also known as cancer immunology. It is a branch of immunology that studies interactions between the immune systems and the cancer cells. It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease.

Related Journals of Tumour Immunology

Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Chemotherapy: Open Access, Journal of Tumor Marker Oncology, Tumor Diagnostik und Therapie, Tumor Research

Necrosis

Necrosis is the death of most or all of the cells in an organ or tissue due to disease, injury, or failure of the blood supply. Necrosis is caused by external factors to the cell or tissue, such as infection, toxins, or trauma that result in the unregulated digestion of cell components.

Related Journals of Necrosis

Cell & Developmental Biology, Cell Science & Therapy, Tissue Science & Engineering, Cell Biology: Research & Therapy, Cell Death and Differentiation, Cell death & disease, Journal of Cell Death

Nucleic Acid Research

Nucleic Acid Research is the research on nucleic acids such as DNA, RNA and related work. It deals with the physical, chemical and biological aspects of the nucleic acids.

Related Journals of Nuclie Acid Research

Cellular and Molecular Biology, Gene Technology, Molecular Cloning & Genetic Recombination, DNA and Cell Biology, Mobile DNA, Mutation Research DNAging, DNA Reporter

Immune Suppression

Immunosuppression involves an act that decreases the activation or efficacy of the immune system. Some portions of the immune system itself have immuno-suppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.

Related Journals of Immunosuppression

Journal of Immunology, Nature Immunology, Nature Reviews Immunology, Annual Review of Immunology, Journal of Allergy and Clinical Immunology, Trends in Immunology, European Journal of Immunology

Immunosurveillance

Immunosurveillance is a term used to describe the processes by which cells of the immune system look for and recognise foreign pathogens, such as bacteria and viruses, or pre-cancerous and cancerous cells in the body. Cancer immunosurveillance appears to be an important host protection process that decreases cancer rates through inhibition of carcinogenesis and maintaining of regular cellular homeostasis.

Related Journals of Immunosurveillance

Current Opinion in Immunology, Allergy: European Journal of Allergy and Clinical Immunology, International Immunology, Clinical and Experimental Immunology, Immunology, Seminars in Immunology

Tumor Immunity

The immune response to foreign antigens consists of humoral (eg, antibodies) and cellular mechanisms. Most of the humoral responses cannot prevent tumor growth. However, effector cells, such as T cells, macrophages, and natural killer cells, have relatively effective tumoricidal abilities.

Related Journals of Tumour Immunity

Cancer Clinical Trials, Cancer Medicine & Anti Cancer Drugs, Chemotherapy: Open Access, Journal of Tumor Marker Oncology, Tumor Diagnostik und Therapie, Tumor Research

Immunotherapy or biologic therapy

Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response. It uses materials either made by the body or in a laboratory to improve, target, or restore immune system function. It is not entirely clear how immunotherapy treats cancer.

Related Journals of Immunotherapy or biologic therapy

Immunobiology, Immunotherapy: Open Access, Immunome Research, Cancer Immunology and Immunotherapy, Journal of Immunotherapy, Immunotherapy, International Journal of Immunotherapy

Metastatic Cancer

Metastatic cancer is cancer that has spread from the place where it first started to another place in the body. A tumor formed by metastatic cancer cells is called a metastatic tumor or a metastasis. The process by which cancer cells spread to other parts of the body is also called metastasis.

Related Journals of Metastatic Cancer

Cancer Research, Nature Reviews Cancer, Journal of the National Cancer Institute, Clinical Cancer Research, Cancer Cell, Cancer, International Journal of Cancer

Systems of Immune

The immune system is a system of many biological structures and processes within an organism that protects against disease. To function properly, an immune system must detect a wide variety of agents, known as pathogens, from viruses to parasitic worms, and distinguish them from the organism's own healthy tissue.

Related Journals of Systems of Immune

Clinical Immunology, Molecular Immunology, Cancer Immunology and Immunotherapy, Cancer Immunology and Immunotherapy, Clinical and Vaccine Immunology, Immunology and Cell Biology, Cellular Immunology

Chemotherapies

Chemotherapy is a type of cancer treatment that uses chemical substances, especially one or more anti-cancer drugs that are given as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent, or it may aim to prolong life or to reduce symptoms.

Related Journals of Chemotherapies

Chemotherapy: Open Access, Antimicrobial Agents and Chemotherapy, Cancer Chemotherapy and Pharmacology, Chemotherapy, Journal of Chemotherapy, Japanese Journal of Chemotherapy, Antibiotics and chemotherapy

Cancer Radioimmunotherapy

Radioimmunotherapy (RIT) uses an antibody labelled with a radionuclide to deliver cytotoxic radiation to a target cell. In cancer therapy, an antibody with specificity for a tumor-associated antigen is used to deliver a lethal dose of radiation to the tumor cells. The ability for the antibody to specifically bind to a tumor-associated antigen increases the dose delivered to the tumor cells while decreasing the dose to normal tissues.

Related Journals of Cancer Radioimmunotherapy

Imaging and Interventional Radiology, OMICS Journal of Radiology, Radiotherapy and Oncology, Reports of Practical Oncology and Radiotherapy, Journal of Radiotherapy in Practice

Cellular Immunotherapy

Cellular Immunotherapy has the potential to be a highly targeted alternative, with low toxicity to normal tissues but a high capacity to eradicate tumor. It includes the approaches that generate cellular therapies using active immunization with cells, proteins, peptides, or nucleic acids, as well as efforts that use adoptive transfer of effector cells that directly target antigens on malignant cells.

Related Journals of Cellular Immunotherapy

Cancer Immunology and Immunotherapy, Journal of Immunotherapy, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Immunotherapy, International Journal of Immunotherapy, Serodiagnosis and Immunotherapy in Infectious Disease

Cancer Immunology

Cancer Immunology is also known as tumour immunology. It is a branch of immunology that studies interactions between the immune systems and the cancer cells. It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease.

Related Journals of Cancer Immunology

Cancer Science, Genes Chromosomes and Cancer, Cancer Immunology and Immunotherapy, Cancer Gene Therapy, Molecular Cancer, Cancer Genetics and Cytogenetics

Tumour Immunity

The involvement of the immune system in the host response to tumors is complex and involves lymphocytes and lymphocyte-derived mediators, as well as inflammatory cells and various other agents such as complement. These activities are not confined to cytodestructive processes; recent studies demonstrate that the migration characteristics of tumor cells may be modified by immunologically derived substances.

Related Journals of Tumour Immunity

Journal of Tumor Marker Oncology, Rare Tumors, Tumor, Tumor Research, Cancer Case Presentations: The Tumor Board

Cancer Immunoediting

Immunoediting is characterized by changes in the immunogenicity of tumours due to the anti-tumour response of the immune system, resulting in the emergence of immune-resistant variants. It consists of 3 phases- elimination, equilibrium and escape.

Related Journals of Cancer Immunoediting

Journal of the National Cancer Institute. Monographs, Cancer Investigation, Cancer Genetics and Cytogenetics, European Journal of Cancer Prevention, Cancer Journal

Immunotherapeutic agents

Immunotherapeutic agents use or modify immune mechanisms. Use of these agents is rapidly evolving; new classes, new agents, and new uses of current agents are certain to be developed. Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response".

Related Journals of Immunotherapeutic agents

Human Vaccines and Immunotherapeutics, Immunotherapy: Open Access, Immunotherapy, International Journal of Immunotherapy, Cancer Immunology and Immunotherapy

Immunogene response

Immunogenicity is the ability of a particular substance, such as an antigen or epitope, to provoke an immune response in the body of a human or animal. In other words, immunogenicity is the ability to induce a humoral and/or cell mediated immune response.

Related Journals of Immunogene response

Immunogenetics, International Journal of Immunogenetics, Experimental and Clinical Immunogenetics, Reviews in Immunogenetics, Immunology and Immunogenetics Insights

Bladder Carcinoma in Situ

The cancerous cells appear to be present and proliferating in an abnormal huge quantity within the line of epithelial cells of urinary bladder is termed as Bladder CIS (Carcinoma in situ). The term CIS is also known as in situ neoplasm where the cancerous cells accumulate as a neoplasm on the outer dermis but fails to penetrate the epithelial wall and doesn’t spread into the inner one.

Related Journals of Bladder Carcinoma in Situ

Clinical Genitourinary Cancer, Breast Cancer Research, Prostate Cancer and Prostatic Diseases, Clinical Colorectal Cancer, Gastric and Breast Cancer

Transitional cell carcinoma (TCC)

The most common type of urinary cancer also known as the creeping tumor arises from the transitional dermis and spreads along the urothelial cellular lining of the organs of urinary system which hails damage to urinary system, kidney, urinary bladder, and accessory organs. The cancerous cells are formed in the renal pelvis and ureter.

Related Journals of Transitional Cell Carcinoma (TCC)

Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas, Clinical Genitourinary Cancer, Breast Cancer Research, Prostate Cancer and Prostatic Diseases, Clinical Colorectal Cancer, Gastric and Breast Cancer

Recently Published Articles

Human Mesenchymal Stem Cell Transfusion for End Stage Liver Disease: A Case Series and Literature Review

Wen-Bo Meng, Bing Bai, Ying Li, Jian-jun Zhang, Yong-long Guo, Wen-Ce Zhou, Yan Li and Xun Li

 
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version